This page contains an up-to-date list of the important changes to RBM’s products and assays. These changes are made as part of our ongoing efforts to improve the quality of our assays and the data we provide. We strive to deliver superior services by emphasizing reliable data and aim to make customers aware of information that may impact their projects as soon as possible.

If you have questions about any of the items contained in the following tables, please contact RBM’s Client Services team

Need Immediate Assistance?

P: (512) 835-8026 / Toll Free: (866) 726-6277
   

Click the year you wish to view to expand/collapse the assay change log.

Assay Change Log

2024

Assay or Product Description of Change Effective Date
Immunoglobulin A (IgA) Assay moved to simplex 08-Mar-2024
Neurofilament heavy polypeptide (pNF-H) Assay added to service offerings 28-Feb-2024
Endoglin Removed from service offerings 13-Feb-2024
Macrophage inflammatory protein 3 beta (MIP-3 beta) Assay was redeveloped using a new capture and detection antibody 23-Jan-2024
Interleukin-12 Subunit p40 (IL-12p40) Assay moved to a different multiplex 04-Jan-2024
Interleukin-12 Subunit p70 (IL-12p70) Assay moved to a different multiplex 04-Jan-2024

2023

Assay or Product Description of Change Effective Date
Progranulin Assay added to service offerings 21-Dec-2023
Phospho-Tau181 (pTau181) Assay added to service offerings 23-Oct-2023
Thyroid-Stimulating Hormone (TSH) Assay was redeveloped using new capture and detection antibodies 10-Oct-2023
Myeloid cell surface antigen CD33 Assay added to service offerings 30-Aug-2023
Intercellular Adhesion Molecule 1 (ICAM-1, HMPC111) Multiplex dilution adjusted 28-Jul-2023
Interferon gamma Induced Protein 10 (IP-10, HMPC111) Multiplex dilution adjusted 28-Jul-2023
Interleukin-1 receptor antagonist (IL-1ra, HMPC111) Multiplex dilution adjusted 28-Jul-2023
Interleukin-2 receptor alpha (IL-2 receptor alpha, HMPC111) Multiplex dilution adjusted 28-Jul-2023
Matrix Metalloproteinase-3 (MMP-3, HMPC111) Multiplex dilution adjusted 28-Jul-2023
MHC class I chain-related protein A (MICA, HMPC111) Multiplex dilution adjusted 28-Jul-2023
Monocyte Chemotactic Protein 2 (MCP-2, HMPC111) Multiplex dilution adjusted 28-Jul-2023
Monokine Induced by Gamma Interferon (MIG, HMPC111) Multiplex dilution adjusted 28-Jul-2023
Epidermal Growth Factor Receptor (EGFR) assay moved to simplex and redeveloped using a new detection antibody 25-Jul-2023
Glucagon-like Peptide 1, total (GLP-1, total) assay moved to simplex and was redeveloped using a new detection antibody 17-Jul-2023
Beta Amyloid 42 Simoa (AB20 Simoa) Assay added to service offerings 11-Jul-2023
Beta Amyloid 40 Simoa (AB40 Simoa) Assay added to service offerings 07-Jul-2023
Periostin (Fibrosis) Assay has been removed from service offerings 07-Jul-2023
Hepatocyte Growth Factor receptor (HGF) Multiplex dilution adjusted 14-Jun-2023
Luteinizing Hormone (LH) Assay removed from service offerings 02-Jun-2023
Haptoglobin Assay redeveloped using new capture and detection antibodies 04-Apr2023
Vitamin D-Binding Protein (VDBP) Assay redeveloped using new capture antibody 04-Apr2023
Tau Assay added to service offerings. 09-Mar-2023
B cell-activating factor (BAFF) Assay did not meet specifications in EDTA plasma and results should be used for information purposes only. 28-Feb-2023
Intercellular Adhesion Molecule 1 (ICAM-1) Assay was redeveloped using a new capture antibody (HMPC111) 28-Feb-2023
Antithrombin-III (AT-III) Assay moved to simplex. 27-Feb-2023
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Assay moved to simplex. 27-Feb-2023

2022

Assay or Product Description of Change Effective Date
6Ckine Assay moved to a different multiplex. 14-Nov-2022
Cancer Antigen 15-3 (CA-15-3) Assay moved to a different multiplex. 14-Nov-2022
Stromal cell-derived factor-1 (SDF-1) Assay moved to a different multiplex. 14-Nov-2022
Apolipoprotein A-I (Apo AI) Assay was removed from service offerings. 21-Jul-2022
Apolipoprotein A-II (Apo AII) Assay was removed from service offerings. 21-Jul-2022
Apolipoprotein C-I (Apo C-I) Assay was removed from service offerings. 21-Jul-2022
Apolipoprotein C-III (Apo C-III) Assay was removed from service offerings. 21-Jul-2022
Apolipoprotein H (Apo H) Assay was removed from service offerings. 21-Jul-2022
Transthyretin (TTR) Assay was removed from service offerings. 21-Jul-2022
Microalbumin (Albumin) Assay was removed from service offerings. 14-Jul-2022
Microalbumin (Albumin) Assay was removed from service offerings. 14-Jul-2022
Matrix Metalloproteinase-9, total (MMP-9, total) Assay was removed from service offerings. 21-Jun-2022
CD40 Ligand (CD40L) Assay was redeveloped using a new capture and detection antibodies. 19-Jan-2022
C-Reactive Protein (CRP) Assay was redeveloped using a new capture and detection antibodies. 17-Mar-2022

2021

Assay or Product Description of Change Effective Date
Albumin (Alb) Assay redeveloped using new beads, detection standard and blocker formulation. 29-Nov-21
Human DiscoveryMAP Gastric inhibitory polypeptide, Glycogen phosphorylase isoenzyme BB, Leptin Receptor, Paraoxanase-1, Omentin, Visceral adipose tissue – derived serpin A12, Visfatin, Complement Factor H, Complement Factor H – Related Protein 1, Transferrin receptor protein 1, C-C motif chemokine 15 (CCL15), C-Peptide, Nerve Growth Factor beta were removed from product. 03-Nov-21
Human NeuroMAP Complement Factor H, Complement Factor H – Related Protein 1, Transferrin receptor protein 1, and Nerve growth factor beta were removed from product. 03-Nov-21
I-309 (C-C motif chemokine ligand I) (I-309 Luminex) Luminex assay was removed from service offerings. 27-Sept-21
Microalbumin (ALB) Assay was redeveloped using new beads, detection standard and blocker formulation. 14-Sept-21
Interleukin-31 (IL-31 Luminex) Assay removed from service offerings. 8-July-21
Interleukin-22 (IL-22) Assay unit updated. 8-July-21
Collagen IV (Collagen IV) Assay removed from service offerings. 07-July-21
Interleukin-1 beta Simoa (IL-1 beta Simoa) Assay was redeveloped using a new standard and sample diluent. 24-May-21
Macrophage Inflammatory Protein-1 beta (MIP-1 beta) Assay moved to a different multiplex. 28-Apr-21
Elafin (Elafin) Assay has been added to service offerings. 26-Apr-21
Glial Fibrillary Acidic Protein Simoa (GFAP Simoa) Assay added to service offerings. 26-Mar-21
Fibroblast Growth Factor 23 Simoa (FGF-23 Simoa) Assay added to service offerings. 18-Mar-21
Interleukin-17F Simoa (IL-17F Simoa) Assay added to service offerings. 18-Mar-21
Interleukin-17F Simoa (IL-17F Simoa) Assay did not meet specifications for antibody competition in EDTA plasma and results should be used for information purposes only 18-Mar-21
Granzyme B Simoa (Granzyme B Simoa) Assay added to service offerings. 01-Feb-21
Human DiscoveryMAP Apolipoprotein D was removed from product. 28-Jan-21
Human NeuroMAP Apolipoprotein D was removed from product. 28-Jan-21
Human CardiovascularMAP Apolipoprotein D was removed from product. 28-Jan-21
Complement Factor H (CFH) Assay added to service offerings. 12-Jan-21

2020

Assay or Product Description of Change Effective Date
Matrix Metalloproteinase-10 (MMP-10) Assay moved to a different multiplex. 23-Dec-20
Complement Factor H (CFH) Assay removed from service offerings. 07-Dec-20
Alpha 1 Microglobulin (A1M) Assay removed from service offerings. 17-Nov-20
Alpha 2 Macroglobulin (A2M) Assay was redeveloped using a new competitor and standard antigen. 04-Nov-20
Progranulin (Progranulin) Assay removed from service offerings. 30-Oct-20
HE4 (HE4) Assay removed from service offerings. 30-Oct-20
Interleukin-1 receptor type 1 (IL-R1) Assay does not meet performance specifications in serum. 26-Oct-20
Immunoglobulin E (IgE) Assay added to service offerings. 20-Oct-20
Interleukin-23 Simoa (IL-23 Simoa) Assay added to service offerings. 16-Sep-20
Interleukin-15 (IL-15) Assay was redeveloped and moved to a different multiplex. 11-Sep-20
Myeloid Progenitor Inhibitory Factor 1 (MPIF-1) Assay was redeveloped and moved to a different multiplex. 20-Aug-20
Programmed Cell Death Protein 1 Simoa (PD-1 Simoa) Assay added to service offerings. 23-Jul-20
Programmed Death-Ligand 1 Simoa (PD-L1 Simoa) Assay added to service offerings. 14-Jul-20
Interleukin-2 receptor alpha (IL-2 receptor alpha) Assay moved to a different multiplex. 29-Jun-20
Latency-Associated Peptide of Transforming Growth Factor beta 1 (LAP-TGF-b1) Assay moved to a different multiplex. 29-Jun-20
Latency-Associated Peptide of Transforming Growth Factor beta 1 (LAP-TGF-b1) Assay meets specifications in serum. 29-Jun-20
Eotaxin-2 Assay moved to a different multiplex. 29-Jun-20
Eotaxin-2 Assay meets specifications in EDTA plasma. 29-Jun-20
B Lymphocyte Chemoattractant (BLC) Assay removed from Luminex service offerings 25-Jun-20
Insulin-like Growth Factor-Binding Protein 2 (IGFBP-2) Multiplex dilution adjusted 22-Jun-20
Macrophage Migration Inhibitory Factor (MIF) Multiplex dilution adjusted 22-Jun-20
Eotaxin-3 Multiplex dilution adjusted 22-Jun-20
Angiopoietin-2 (Ang-2) Multiplex dilution adjusted 22-Jun-20
Interleukin-15 (IL-15) Assay removed from service offerings. 29-Jun-20
Aggrecan Core Protein (Aggrecan) Assay removed from service offerings. 15-Jun-20
Interleukin-21 Simoa (IL-21 Simoa) Assay added to service offerings. 09-Jun-20
Eotaxin-2 Assay does not meet performance specifications in EDTA plasma. 19-May-20
Latency-Associated Peptide of Transforming Growth Factor beta 1 (LAP-TGF-b1) Assay does not meet performance specifications in serum. 19-May-20
Chromogranin-A (CgA) Assay removed from service offerings. 29-May-20
Nerve Growth Factor beta (NGF-beta) Assay moved to a different multiplex. 29-May-20
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) Assay discontinued from human services. 31-Mar-20
T Lymphocyte-secreted protein I-309 Simoa (I-309 Simoa) Assay added to service offerings. 12-May-20
Human OncologyMAP Epithelial cell adhesion molecule, Protein S100 A6, and Glucose 6 phosphate isomerase, A disintegrin and metalloproteinase with thrombospondin motifs 8, Folate receptor gamma, and Aggrecan core protein removed from product. . 11-May-20
Human DiscoveryMAP Epithelial cell adhesion molecule, Protein S100 A6, and Glucose 6 phosphate isomerase, A disintegrin and metalloproteinase with thrombospondin motifs 8, Folate receptor gamma, and Aggrecan core protein removed from product. 11-May-20
Metalloproteinase-10 (MMP-10) Assay discontinued from human services. 27-Feb-20
Sex Hormone Binding Globulin (SHBG) Assay added to service offerings. 20-Mar-20
Interferon-lambda 1 Simoa (IFN-lambda 1 Simoa) Assay added to service offerings. 27-Feb-20
IL-22 Simoa Assay added to service offerings. 25-Feb-20
IL-12p70 Simoa Assay added to service offerings. 25-Feb-20
Human DiscoveryMAP Assay moved to a different multiplex. 21-Jan-20
Human OncologyMAP CD5 Antigen like, Fetuin-A, Vitamin K Dependent Protein S, Endostatin, Alpha-1-acid glycoprotein 1, Retinol binding protein 4, and Hemopexin were removed from product. 21-Jan-20
Human CardiovascularMAP Fetuin-A and Vitamin K-Dependent Protein S were removed from product. 21-Jan-20
Vitronectin Assay moved to a different multiplex. 15-Jan-20
Insulin-like Growth Factor-Binding Protein 7 (IGFBP-7) Assay discontinued from human services. 15-Jan-20
Sex Hormone Binding Globulin (SHBG) Assay discontinued from human services. 10-Jan-20

2019

Assay or Product Description of Change Effective Date
Interleukin-4 Simoa (IL-4 Simoa) Assay added to service offerings. 26-Nov-19
Interleukin-19 Simoa (IL-19 Simoa) Assay added to service offerings. 18-Dec-19
Tectranectin Assay discontinued from human services. 26-Dec-19
Macrophage-Stimulating Protein (MSP) Assay discontinued from human services. 26-Dec-19
Gelsolin Assay discontinued from human services. 26-Dec-19
Fibulin-1C (Fib-1C) Assay discontinued from human services. 26-Dec-19
Dopamine beta-hydroxylase (DBH) Assay discontinued from human services. 4-Oct-19
Immunoglobulin E (IgE) Assay discontinued from human services. 6-Sep-19
Apolipoprotein B (Apo B) Assay added to service offerings. 8-Aug-19
Uteroglobin Assay discontinued from human services. 7-Aug-19
Interleukin-23 (IL-23) Assay discontinued from human services. 19-Jun-19
Apolipoprotein E (Apo E) Assay discontinued from human services. 17-Jun-19
Follicle-Stimulating Hormone (FSH) Assay adjusted to meet industry standards. 31-May-19
Oncostatin-M Simoa (OSM Simoa) Assay added to service offerings. 06-May-19
Oncostatin-M-specific receptor subunit beta Simoa (OSMR Simoa) Assay added to service offering. 06-May-19
Tumor Necrosis Factor Ligand Superfamily Member 14 Total Simoa (LIGHT Total Simoa) Assay added to service offerings. 06-May-19
Apolipoprotein B (Apo B) Assay discontinued from human services. 18-Apr-19
Apolipoprotein(a) (Lp(a)) Assay was redeveloped using a new antigen. 07-Mar-19
E-Selectin Assay blocker formulation was adjusted. 10-Jan-19
Monocyte Chemotactic Protein 2 (MCP-2) Assay blocker formulation was adjusted. 10-Jan-19
Interleukin-6 receptor (IL-6r) Assay blocker formulation was adjusted. 10-Jan-19
Monocyte Chemotactic Protein 4 (MCP-4) Assay blocker formulation was adjusted. 10-Jan-19
Macrophage Inflammatory Protein-3 alpha (MIP-3 alpha) Assay blocker formulation was adjusted. 10-Jan-19
Myeloid Progenitor Inhibitory Factor 1 (MPIF-1) Assay blocker formulation was adjusted. 10-Jan-19
Monokine Induced by Gamma Interferon (MIG) Assay moved to a different multiplex. 10-Jan-19
Interferon gamma Induced Protein 10 (IP-10) Assay moved to a different multiplex. 10-Jan-19
Tissue type Plasminogen activator (tPA) Assay was redeveloped using a new antigen. 11-Jan-19
Urokinase-type Plasminogen Activator (uPA) Assay was redeveloped using a new antigen. 11-Jan-19
Galectin-3 Assay does not meet performance specifications in EDTA plasma. 11-Jan-19

2018

Assay or Product Description of Change Effective Date
Adiponectin Assay discontinued from human services. 13-Dec-18
Interleukin-13 Simoa (IL-13 Simoa) Assay added to service offerings. 7-Dec-18
Interleukin-17C Simoa (IL-17C Simoa) Assay added to service offerings. 7-Dec-18
Interleukin-8 (IL-8) Assay moved to a different multiplex. 29-Nov-18
Cellular Fibronectin (cFIB) Assay discontinued from human services. 29-Nov-18
Interleukin-9 Simoa (IL-9 Simoa) Assay added to service offerings. 26-Nov-18
Receptor Activator of Nuclear Factor Kappa B Ligand Simoa (RANKL Simoa) Assay added to service offerings. 14-Nov-18
Tumor Necrosis Factor Ligand Superfamily Member 14 Simoa (LIGHT, free Simoa) Assay added to service offerings. 14-Nov-18
Interleukin-8 Simoa (IL-8 Simoa) Assay added to service offerings. 16-Oct-18
Interleukin-8 (IL-8) Assay moved to a different multiplex. 11-Oct-18
Thymus-Expressed Chemokine (TECK) Assay was redeveloped using a new antigen. 14-Sept-18
Apolipoprotein D (Apo D) Assay redeveloped with new capture and detection antibodies. 23-Aug-18
Interleukin-18 binding protein (IL-18bp) Assay redeveloped with a new antigen. 15-Aug-18
Osteocalcin Assay meets performance specifications in EDTA plasma. 02-Aug-18
ST2 Assay meets performance specifications in Serum. 02-Aug-18
CD163 Assay redeveloped with new antigen. 02-Aug-18
CD163 Assay discontinued from human services. 03-Jul-18
Osteocalcin Assay does not meet performance specifications in EDTA plasma. 03-Jul-18
ST2 Assay does not meet performance specifications in Serum. 03-Jul-18
Transforming Growth Factor beta-3 (TGF-beta 3) Assay discontinued from human services. 04-Apr-18
Vaspin Assay was redeveloped using a new capture antibody. 20-Mar-18
Omentin Assay does not meets performance specifications in Serum. 20-Mar-18
Cartilage Oligomeric Matrix Protein (COMP) Assay added to human services. 09-Mar-18
Alpha-1-Microglobulin (A1Micro, urine) Assay discontinued from human services. 06-Mar-18
Tamm-Horsfall Urinary Glycoprotein (THP, urine) Assay discontinued from human services. 06-Mar-18
Trefoil Factor 3 (TFF3, urine) Assay discontinued from human services. 06-Mar-18
Interferon-alpha (IFN-alpha) Assay redeveloped with new capture and detection antibodies. 21-Feb-18
CD27 antigen (CD27) Assay redeveloped with a new antigen. 06-Feb-18
CD27 antigen (CD27) Assay blocker formulation was adjusted. 06-Feb-18
Fibroblast Growth Factor 21 (FGF-21) Assay blocker formulation was adjusted. 06-Feb-18
Fibroblast growth factor 23 (FGF-23) Assay blocker formulation was adjusted. 06-Feb-18
Insulin-like Growth Factor-Binding Protein 7 (IGFBP-7) Assay blocker formulation was adjusted. 06-Feb-18
Interleukin-1 receptor type 1 IL-1RI Assay blocker formulation was adjusted. 06-Feb-18
Progranulin Assay blocker formulation was adjusted. 06-Feb-18
Thymus-Expressed Chemokine (TECK) Assay blocker formulation was adjusted. 06-Feb-18
Thymus-Expressed Chemokine (TECK) Assay blocker formulation was adjusted. 06-Feb-18
Tissue Inhibitor of Metalloproteinases 3 (TIMP-3) Assay blocker formulation was adjusted. 06-Feb-18
Interleukin-18-binding protein (IL-18bp) Assay discontinued from human services. 26-Jan-18
Angiopoietin-1 (ANG-1) Assay meets performance specifications in EDTA plasma. 25-Jan-18
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) Assay meets performance specifications in serum. 25-Jan-18
Serum Amyloid A Protein (SAA) Assay meets performance specifications in serum. 19-Jan-18
Ficolin-3 Assay redeveloped using a new capture antibody. 19-Jan-18
Neutrophil Activating Peptide 2 (NAP-2) Assay redeveloped using a new capture antibody. 19-Jan-18
Serum Amyloid A Protein (SAA) Assay redeveloped using new capture and detection antibodies. 19-Jan-18

2017

Assay or Product Description of Change Effective Date
Amphiregulin (AR) Assay blocker formulation was adjusted. 06-Nov-17
Epidermal Growth Factor (EGF) Assay blocker formulation was adjusted. 06-Nov-17
Epidermal Growth Factor Receptor (EGFR) Assay blocker formulation was adjusted. 06-Nov-17
Epiregulin (EPR) Assay blocker formulation was adjusted. 06-Nov-17
Heparin-Binding EGF-Like Growth Factor (HB-EGF) Assay blocker formulation was adjusted. 06-Nov-17
Placenta Growth Factor (PLGF) Assay blocker formulation was adjusted. 06-Nov-17
Platelet-Derived Growth Factor BB (PDGF-BB) Assay blocker formulation was adjusted. 06-Nov-17
Tenascin-C (TN-C) Assay blocker formulation was adjusted. 06-Nov-17
Growth/differential factor 11 Simoa (GDF-11) Assay added to human services. 30-Aug-17
Neurofilament Light Chain Simoa (NF-L) Assay added to human services. 24-Aug-17
TruCulture OptiMAP™ v. 1.0 Product added to human services. 23-Aug-17
Serum Amyloid P-Component (SAP) Assay moved to a different multiplex. 22-Jun-17
CD40 Antigen (CD40) Assay added to human services. 08-Jun-17
Macrophage Migration Inhibitory Factor (MIF) Assay redeveloped with a new antigen. 06-Jun-17
Kidney Injury Molecule-1 Simoa (KIM-1) Assay added to human services. 30-May-17
Immunoglobulin E (IgE) Assay added to human services. 25-May-17
Amphiregulin Simoa (AR) Assay added to human services. 18-May-17
Apolipoprotein B (Apo B) Assay added to human services. 17-May-17
Human OncologyMAP v. 3.0 Product discontinued from human services. 3-Apr-17
HE4 Assay adjusted to meet industry standards. 24-Apr-17
Apolipoprotein B (Apo B) Assay discontinued from all human services. 17-Apr-17
Adiponectin Assay added to human services. 13-Apr-17
Interleukin-31 Simoa (IL-31) Assay added to human services. 13-Apr-17
Adiponectin Assay discontinued from all human services. 03-Apr-17
Serotransferrin (Transferrin) Assay added to human services. 03-Apr-17
Monocyte Chemotactic Protein (MCP-4) Assay adjusted to meet industry standards. 03-Apr-17
Interferon-alpha Simoa (IFN-a) Assay added to human services. 23-Jan-17
Osteocalcin Assay added to human services. 10-Feb-17
Immunoglobulin E (IgE) Assay discontinued from all human services. 24-Jan-17
Aldose Reductase Assay discontinued from all human services. 12-Jan-17
Glutathione S-Transferase Mu 1 (GST-M1) Assay discontinued from all human services. 12-Jan-17
Peroxiredoxin-4 (Prx-IV) Assay discontinued from all human services. 12-Jan-17
Phosphoserine Aminotransferase (PSAT) Assay discontinued from all human services. 12-Jan-17
Lactoylglutathione lyase (LGL) Assay discontinued from all human services. 12-Jan-17
Squamous Cell Carcinoma Antigen-1 (SSCA-1) Assay discontinued from all human services. 12-Jan-17
Vascular Endothelial Growth Factor Receptor 3 (VEGFR-3) Assay added to human services. 09-Jan-17

2016

Assay or Product Description of Change Effective Date
Mesothelin (MSLN) Assay discontinued from all human services. 21-Dec-16
Growth/differentiation factor 11 (GDF-11) Assay discontinued from all human services. 13-Dec-16
Hepatocyte Growth Factor (HGF) Assay added to human services. 04-Nov-16
Beta-microseminoprotein (PSP94) Assay discontinued from all human services. 21-Oct-16
Cystatin-A Assay discontinued from all human services. 21-Oct-16
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) Assay discontinued from all human services. 21-Oct-16
Cathepsin B (pro) (CTSB) Assay discontinued from all human services. 21-Oct-16
Tenascin-X (TN-X) Assay discontinued from all human services. 21-Oct-16
Lipocalin-1 (LCN1) Assay discontinued from all human services. 21-Oct-16
Prostate Specific Antigen, total (tPSA) Assay discontinued from all human services. 21-Oct-16
Interleukin-4 (IL-4) Assay added to human services. 10-Oct-16
Fibulin-1C (Fib-1C) Assay redeveloped using a new standard. 06-Oct-16
Interleukin-4 (IL-4) Assay discontinued from all human services. 08-Sep-16
Ceruloplasmin Assay discontinued from all human services. 01-Sep-16
Granulocyte Colony-Stimulating Factor Simoa (G-CSF) Assay added to human services. 26-Aug-16
Interleukin-12 Subunit p40 Simoa (IL-12p40) Assay added to human services. 16-Aug-16
Dipeptidyl peptidase IV (DPPIV) Assay discontinued from all human services. 12-Aug-16
Monokine Induced by Gamma Interferon (MIG) Assay added to human services. 26-Jul-16
Collagen IV Assay redeveloped using a new detection antibody. 01-Jul-16
Immunoglobulin E (IgE) Assay redeveloped using a new antigen. 28-Jun-16
Periostin Assay redeveloped using a new antibody pair. 23-Jun-16
P-Selectin Assay does not meets performance specifications in EDTA plasma. 23-Jun-16
Osteocalcin Assay discontinued from all human services. 23-Jun-16
Urokinase-type Plasminogen Activator (uPA) Assay meets performance specifications in EDTA plasma. 17-Jun-16
Secreted protein acidic and rich in cysteine (SPARC) Assay discontinued from human services. 09-May-16
Interleukin-4 (IL-4) Assay added to human services. 06-May-16
Serum Amyloid P-Component (SAP) Assay added to human services. 15-Apr-16
Chromogranin-A (CgA) Assay blocker formulation was adjusted. 7-Apr-16
Nerve Growth Factor beta (NGF-beta) Assay blocker formulation was adjusted. 7-Apr-16
Neuronal Cell Adhesion Molecule (Nr-CAM) Assay blocker formulation was adjusted. 7-Apr-16
S100 calcium-binding protein B (S100-B) Assay blocker formulation was adjusted. 7-Apr-16
Sortilin Assay blocker formulation was adjusted. 7-Apr-16
Receptor for advanced glycosylation end products (RAGE) Assay blocker formulation was adjusted. 7-Apr-16
Superoxide Dismutase 1, soluble (SOD-1) Assay blocker formulation was adjusted. 7-Apr-16
Interleukin-4 (IL-4) Assay temporarily discontinued from all human services. 22-Mar-16
Monokine Induced by Gamma Interferon (MIG) Assay temporarily discontinued from all human services. 14-Mar-16
Vascular Endothelial Growth Factor Receptor 3 (VEGFR-3) Assay discontinued from all human services. 01-Mar-16
Hepatocyte Growth Factor (HGF) Assay discontinued from all human services. 01-Mar-16
Urokinase-type plasminogen activator receptor (uPar) Assay redeveloped using a new antibody pair. 26-Feb-16
Serum Amyloid P Component (SAP) Assay discontinued from all human services. 26-Feb-16
Secreted protein acidic and rich in cysteine (SPARC) Assay meets performance specifications in EDTA plasma. 16-Feb-16
Vascular endothelial growth factor D (VEGF-D) Assay redeveloped using a new antibody part number. 16-Feb-16
C-Reactive Assay discontinued from all rodent services. 01-Feb-16
Fibrinogen Assay discontinued from all rodent services. 01-Feb-16
Serum Amyloid P-Component Assay discontinued from all rodent services. 01-Feb-16
Osteocalcin Assay redeveloped using new antigen. 26-Jan-16
Interleukin-2 Simoa (IL-2) Assay added to human services. 26-Jan-16
Insulin-like Growth Factor-Binding Protein 3 Assay discontinued from human services. 13-Jan-16
Insulin-like Growth Factor-Binding Protein 4 Assay discontinued from human services. 13-Jan-16
Insulin-like Growth Factor-Binding Protein 5 Assay discontinued from human services. 13-Jan-16
Insulin-like Growth Factor-Binding Protein 6 Assay discontinued from human services. 13-Jan-16
A disintegrin and metalloproteinase with thrombospondin motifs 8 Assay added to human services. 11-Jan-16
Folate receptor gamma Assay added to human services. 11-Jan-16
Growth/differentiation factor 11 Assay added to human services. 11-Jan-16
Aggrecan core protein Assay added to human services. 11-Jan-16
C-C motif chemokine Assay added to human services. 11-Jan-16
Uteroglobin Assay added to human services. 11-Jan-16

2015

Assay or Product Description of Change Effective Date
CD40 antigen Assay discontinued from human services. 16-Dec-15
Vitronectin Assay added to human services. 16-Dec-15
Serotransferrin Assay discontinued from human services. 15-Dec-15
Pentraxin-3 Assay discontinued from human services. 11-Dec-15
Glycogen phosphorylase isoenzyme BB Assay added to human services. 11-Dec-15
Interleukin-13 Assay redeveloped using new antigen. 07-Dec-15
Alpha-1-Antichymotrypsin Assay discontinued from all human services. 30-Nov-15
Apolipoprotein A-IV Assay discontinued from all human services. 30-Nov-15
Heat Shock Protein 60 Assay discontinued from all human services. 30-Nov-15
Proinsulin, intact Assay discontinued from all human services. 30-Nov-15
Proinsulin, total Assay discontinued from all human services. 30-Nov-15
Fibroblast Growth Factor-basic Assay discontinued from all human services. 30-Nov-15
Cartilage Oligomeric Matrix Protein Assay discontinued from all human services. 30-Nov-15
Complement component C1q receptor Assay discontinued from all human services. 30-Nov-15
Chemerin Assay discontinued from all human services. 30-Nov-15
Selenoprotein P Assay discontinued from all human services. 30-Nov-15
Angiopoietin-related protein 3 Assay discontinued from all human services. 30-Nov-15
Peptidase D Assay discontinued from all human services. 30-Nov-15
Thrombospondin-4 Assay discontinued from all human services. 30-Nov-15
Interleukin-5 Simoa (IL-5) Assay added to human services. 27-Oct-15
Thyroglobulin Assay redeveloped using a new capture and detection antibody. 23-Oct-15
Peroxiredoxin-4 Assay added to human services. 15-Oct-15
Tissue Inhibitor of Metalloproteinases 1 Assay discontinued from human services (urine products only). 15-Oct-15
B Lymphocyte Chemoattractant Simoa (BLC Simoa)Assay added to human services.14-Aug-15
Angiopoietin-related protein 4Assay added to human services.23-July-15
Bone morphogenetic protein 9Assay added to human services.23-July-15
SclerostinAssay added to human services.23-July-15
Secreted protein acidic and rich in cysteineAssay added to human services.23-July-15
MidkineAssay discontinued from all human services. 17-July-15
Glycogen phosphorylase isoenzyme BBAssay discontinued from all human services. 17-Jun-15
Complement C3 (C3)Assay discontinued from all human services. 17-Jun-15
Peroxiredoxin-4Assay discontinued from all human services. 17-Jun-15
Apolipoprotein A-IAssay added to human services.11-Jun-15
Vascular Endothelial Growth Factor C (VEGF-C)Assay discontinued from all human or mouse services.11-Jun-15
Sex Hormone-Binding Globulin (SHBG)Assay moved to a different multiplex.29-Apr-15
Leucine-Rich Alpha-2-Glycoprotein (LRG1)Assay discontinued from all human services.29-Apr-15
Serum Amyloid A Protein (SAA)Assay did not meet performance specifications in serum and results should be used for information purposes only. 17-Apr-15
Alpha-2-Macroglobulin (A2M)Assay meets performance specifications in plasma EDTA. 15-Apr-15
Interferon Gamma Simoa (IGN-g)Assay added to human services.6-Apr-15
Interleukin-1 beta Simoa (IL-1 b)Assay added to human services.31-Mar-15
Interleukin-10 Simoa (IL-10)Assay added to human services.31-Mar-15
ClusterinAssay redeveloped using new antigen.20-Mar-15
Creatine Kinase (CK-MB)Assay discontinued from human services.19-Mar-15
GLP-1 activeAssay discontinued from human services.12-Mar-15
InsulinAssay added to human services.12-Mar-15
LumicanAssay discontinued from human services.6-Mar-15
Tumor Necrosis Factor-alpha (TNF-α)Assay added to human services.4-Mar-15
Interleukin-6 Simoa (IL-6)Assay added to human services.4-Mar-15
Cadherin-13 (T-cad) Assay added to human services.24-Feb-15
Midkine Assay added to human services.24-Feb-15
ApopotosisMAP 1.0 Product discontinued from human services.18-Feb-15
InsulinAssay discontinued from all human services.11-Feb-15
Peroxiredoxin-4 (Prx-IV)Assay added to human services.9-Feb-15
Protein S100-A6 (S100-A6)Assay added to human services.9-Feb-15
Glucose-6-phosphate Isomerase (G6PI)Assay moved to a different multiplex9-Feb-15
Lactoylglutathione lyase (LGL)Assay moved to a different multiplex9-Feb-15
Squamous Cell Carcinoma Antigen-1 (SCCA-1)Assay moved to a different multiplex9-Feb-15
Phosphoserine Aminotransferase (PSAT)Assay moved to a different multiplex9-Feb-15
Glutathione S-Transferase Mu 1 (GST-M1)Assay moved to a different multiplex9-Feb-15
Epithelial cell adhesion molecule (EpCam)Assay moved to a different multiplex9-Feb-15
Aldose ReductaseAssay moved to a different multiplex9-Feb-15
Protein S100-A4 (S100-A4)Assay discontinued from all human services.9-Feb-15
DiscoveryMAP 175+Product discontinued from human services.3-Feb-15
DiscoveryMAP 250+Product discontinued from human services.3-Feb-15
ExplorerMAP Product added to human services.3-Feb-15

2014

Assay or Product Description of Change Effective Date
Complement C3 (C3)Assay discontinued from all human services29-Dec-14
Glutathione S-Transferase alpha (GST-alpha)Assay discontinued from all human services24-Nov-14
Secreted Protein Acidic and Rich in Cysteine (SPARC)Assay did not meet performance specifications in plasma and results should be used for information purposes only. 11-Nov-14
RANTES Assay discontinued from all rodent services. 16-Oct-14
Vitronectin Assay discontinued from all human services. 15-Oct-14
Beta Amyloid1-40 (AB 40) Assay adjusted to meet industry standards. 08-Oct-14
Beta Amyloid 1-42 (AB-42) Assay adjusted to meet industry standards. 08-Oct-14
Lymphotactin Assay discontinued from all rodent services. 07-Oct-14
Lipocalin-1 (LCN-1) Assay added to human services 07-Oct-14
PYY Assay discontinued from all human services. 23-Sep-14
Antithrombin-III Assay added to CardiovascularMAP 05-Sep-14
Ficolin-3 Assay added to CardiovascularMAP 05-Sep-14
Neurpilin-1 Assay added to CardiovascularMAP 05-Sep-14
Neutrophil Activating Peptide 2 Assay added to CardiovascularMAP 05-Sep-14
Pigment Epithelium Derived Factor Assay added to CardiovascularMAP 05-Sep-14
Serum Amyloid A Protein Assay added to CardiovascularMAP 05-Sep-14
Thrombin-Activatable Fibrinolysis Assay added to CardiovascularMAP 05-Sep-14
Osteopontin Assay removed from CardiovascularMAP 05-Sep-14
Glucagon Assay discontinued from all human services 05-Sep-14
Receptor tyrosine-protein kinase erbB-3 Assay did not meet specifications in EDTA plasma 05-Sep-14
Fatty Acid-Binding Protein, adipocyte Assay did not meet specifications in serum 05-Sep-14
Galectin-3 Assay redeveloped using new antibody pair 05-Sep-14
All human products Assay ranges updated 28-Aug-14
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Multiplex buffer composition adjusted. 27-Aug-14
Interferon gamma (IFN-gamma) Multiplex buffer composition adjusted. 27-Aug-14
Interleukin-10 (IL-10) Multiplex buffer composition adjusted. 27-Aug-14
Interleukin-18 (IL-18) Multiplex buffer composition adjusted. 27-Aug-14
Interleukin-2 (IL-2) Multiplex buffer composition adjusted. 27-Aug-14
Interleukin-3 (IL-3) Multiplex buffer composition adjusted. 27-Aug-14
Interleukin-4 (IL-4) Multiplex buffer composition adjusted. 27-Aug-14
Interleukin-5 (IL-5) Multiplex buffer composition adjusted. 27-Aug-14
Interleukin-6 (IL-6) Multiplex buffer composition adjusted. 27-Aug-14
Interleukin-7 (IL-7) Multiplex buffer composition adjusted. 27-Aug-14
Interleukin-8 (IL-8) Multiplex buffer composition adjusted. 27-Aug-14
Macrophage Inflammatory Protein-1 alpha (MIP-1 alpha) Multiplex buffer composition adjusted. 27-Aug-14
Macrophage Inflammatory Protein-1 beta (MIP-1 beta) Multiplex buffer composition adjusted. 27-Aug-14
Monocyte Chemotactic Protein 1 (MCP-1) Multiplex buffer composition adjusted. 27-Aug-14
Tumor Necrosis Factor alpha (TNF-alpha) Multiplex buffer composition adjusted. 27-Aug-14
Tumor Necrosis Factor beta (TNF-beta) Multiplex buffer composition adjusted. 27-Aug-14
Human NeuroMAP™ v. 1.0 Product added to human services 08-Aug-14
Cortisol Assay adjusted to meet industry standards. 06-Aug-14
CD 40 antigen (CD40) Multiplex buffer composition adjusted. 04-Aug-14
CD40 Ligand (CD40-L) Multiplex buffer composition adjusted. 04-Aug-14
Erythropoietin (EPO) Assay added to human services 04-Aug-14
Myeloperoxidase (MPO) Assay moved to a different multiplex. 04-Aug-14
Granulocyte Colony-Stimulating Factor (G-CSF) Multiplex buffer composition adjusted. 04-Aug-14
Alpha-Fetoprotein (AFP) Assay adjusted to meet industry standards. 08-Aug-14
Cancer Antigen 125 (CA 125) Assay adjusted to meet industry standards. 04-Aug-14
Antithrombin-III (AT-III) Multiplex buffer composition adjusted. 04-Aug-14
Ficolin-3 Multiplex buffer composition adjusted. 04-Aug-14
Leucine-rich alpha-2-glycoprotein (LRG1) Multiplex buffer composition adjusted. 04-Aug-14
Neutrophil Activating Peptide 2 (NAP-2) Multiplex buffer composition adjusted. 04-Aug-14
Pigment Epithelium Derived Factor (PEDF) Multiplex buffer composition adjusted. 04-Aug-14
Serum Amyloid A Protein (SAP) Multiplex buffer composition adjusted. 04-Aug-14
Thrombin-activable fibrinolysis inhibitor (TAFI) Multiplex buffer composition adjusted. 04-Aug-14
Neuropilin-1 Assay moved to a different multiplex. 04-Aug-14
CD40 Assay discontinued from all rodent services 27-June-14
Myeloperoxidase (MPO) Assay discontinued from all rodent services 27-June-14
CD40 Ligand (CD40-L) Assay discontinued from all rodent services 27-June-14
Complement Factor H Related Protein 1 (CFHR1) Assay moved to a different multiplex 20-June-14
Complement Factor H Related Protein 1 (CFHR1) Assay removed from Human DiscoveryMAP 175+, Human DiscoveryMAP 250+ 20-June-14
Canine KidneyMAP Product removed from rodent services 05-June-14
Rat MetabolicMAP Product removed from rodent services 05-June-14
Apolipoprotein C-I (Apo C-I) Assay added to CardiovascularMAP 06-May-14
Chromogranin-A (CgA) Assay added to CardiovascularMAP 06-May-14
Factor VII Assay added to CardiovascularMAP 06-May-14
Fetuin-A Assay added to CardiovascularMAP 06-May-14
Glucagon-like Peptide 1, active (GLP-1 active) Assay added to CardiovascularMAP 06-May-14
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Assay added to CardiovascularMAP 06-May-14
Insulin Assay added to CardiovascularMAP 06-May-14
Interferon gamma (IFN-gamma) Assay added to CardiovascularMAP 06-May-14
Interferon gamma Induced Protein 10 (IP-10) Assay added to CardiovascularMAP 06-May-14
Interleukin-1 alpha (IL-1 alpha) Assay added to CardiovascularMAP 06-May-14
Interleukin-1 beta (IL-1 beta) Assay added to CardiovascularMAP 06-May-14
Interleukin-6 receptor (IL-6r) Assay added to CardiovascularMAP 06-May-14
Interleukin-10 (IL-10) Assay added to CardiovascularMAP 06-May-14
Matrix Metalloproteinase-9 (MMP-9) Assay added to CardiovascularMAP 06-May-14
Serotransferrin (Transferrin) Assay added to CardiovascularMAP 06-May-14
Vascular Endothelial Growth Factor (VEGF) Assay added to CardiovascularMAP 06-May-14
Vitamin K-Dependent Protein S (VKDPS) Assay added to CardiovascularMAP 06-May-14
Adiponectin Assay added to OncologyMAP 06-May-14
Alpha-2-Macroglobulin (A2Macro) Assay added to OncologyMAP 06-May-14
Angiopoietin-2 (ANG-2) Assay added to OncologyMAP 06-May-14
AXL Receptor Tyrosine Kinase (AXL) Assay added to OncologyMAP 06-May-14
Beta-2-Microglobulin (B2M) Assay added to OncologyMAP 06-May-14
Ciliary Neurotrophic Factor (CNTF) Assay added to OncologyMAP 06-May-14
Fas Ligand (FasL) Assay added to OncologyMAP 06-May-14
FASLG Receptor (FAS) Assay added to OncologyMAP 06-May-14
Ferritin (FRTN) Assay added to OncologyMAP 06-May-14
Fibroblast Growth Factor 4 (FGF-4) Assay added to OncologyMAP 06-May-14
Insulin Assay added to OncologyMAP 06-May-14
Interleukin-6 receptor (IL-6r) Assay added to OncologyMAP 06-May-14
Monocyte Chemotactic Protein 3 (MCP-3) Assay added to OncologyMAP 06-May-14
Plasminogen Activator Inhibitor 1 (PAI-1) Assay added to OncologyMAP 06-May-14
Tissue Inhibitor of Metalloproteinases 1 (TIMP-1) Assay added to OncologyMAP 06-May-14
TNF-Related Apoptosis-Inducing Ligand Receptor 3 (TRAIL-R3) Assay added to OncologyMAP 06-May-14
Transforming Growth Factor beta-3 (TGF-beta-3) Assay added to OncologyMAP 06-May-14
Tumor necrosis factor receptor 2 (TNFR2) Assay added to OncologyMAP 06-May-14
Vascular Cell Adhesion Molecule-1 (VCAM-1) Assay added to OncologyMAP 06-May-14
Rat KidneyMAP v. 1.0 Product removed from rodent services 06-May-14
Bio-Plex Pro™ RBM Rat Kidney Toxicity Service Product added to rodent services 06-May-14
Factor VII Assay discontinued from all rodent products 06-May-14
Adrenomedullin Assay added to human services 06-May-14
Beta Amyloid 1-40 Assay added to human services 06-May-14
Beta Amyloid 1-42 Assay added to human services 06-May-14
Dopamine beta-hydroxylase Assay added to human services 06-May-14
Heat-Shock protein 70 Assay added to human services 06-May-14
Neurofilament heavy polypeptide Assay added to human services 06-May-14
Protein DJ-1 Assay added to human services 06-May-14
HE4 Assay redeveloped using new antibody pair. 01-May-14
CA 72-4 Assay discontinued from all human products 03-Apr-14
AACT Assay redeveloped using new antigen. 27-Mar-14
Apolipoprotein A4 Assay redeveloped using new antigen. 27-Mar-14
HSP60 Assay redeveloped using new antigen. 27-Mar-14
Proinsulin (Total) Assay redeveloped using new antigen. 27-Mar-14
Proinsulin (Intact) Assay redeveloped using new antigen. 27-Mar-14
Midkine Assay discontinued from all human services. 27-Mar-14
TIE-1 Assay discontinued from all human products. 20-Mar-14
Urokinase-type Plasminogen Activator (uPA) This assay did not meet performance specifications in EDTA-plasma and results should be used for information purposes only. 10-Mar-14
Lipocalin 1 (LCN1) Assay discontinued from all human products. 28-Feb-14
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) Assay redeveloped using new antibody pair. 28-Feb-14
tPA Assay redeveloped using new antibody pair. 28-Feb-14
Pulmonary and Activation-Regulated Chemokine Assay moved to a different multiplex. 24-Jan-14
Matrix Metalloproteinase-2 (MMP2) Assay moved to a different multiplex. 24-Jan-14
EN-RAGE Assay moved to a different multiplex and now meets performance specifications in both serum and EDTA-plasma. 24-Jan-14
MHC class I chain-related protein A (MICA) Assay moved to a different multiplex. 23-Jan-14
Apolipoprotein B (Apo B) Multiplex buffer composition adjusted. 14-Jan-14
CD5 Antigen-like (CD5L) Multiplex buffer composition adjusted. 14-Jan-14
Clusterin (CLU) Assay dilution adjusted. 14-Jan-14
Complement factor H-related protein 1 (CFHR1) Multiplex buffer composition adjusted. 14-Jan-14
Fetuin A Multiplex buffer composition adjusted. 14-Jan-14
Growth-regulated protein alpha (GRO-alpha) Assay moved to a different multiplex. 14-Jan-14
Leptin R Assay redeveloped using new antibody pair. 14-Jan-14
Progranulin Assay moved to a different multiplex. 14-Jan-14
Thrombin-activatable fibrinolysis inhibitor (TAFI ) Assay redeveloped using new antibody pair. 14-Jan-14
Vitamin K-Dependent Protein S (VKDPS) Assay redeveloped using new antibody pair. Multiplex buffer composition adjusted. 14-Jan-14
Beta-2-Microglobulin Assay moved to a different multiplex. 13-Jan-14
CD27 antigen Assay added to human services. 13-Jan-14
Clusterin Assay moved to a different multiplex. Assay dilution adjusted. 13-Jan-14
Fibroblast Growth Factor 21 Assay added to human services. 13-Jan-14
Fibroblast Growth Factor 23 Assay added to human services. 13-Jan-14
Insulin-like Growth Receptor Type 1 Assay added to human services. 13-Jan-14
Insulin-like Growth Receptor Type 2 Assay added to human services. 13-Jan-14
Progranulin Assay added to human services. 13-Jan-14
Thymus-Expressed Chemokine Assay added to human services. 13-Jan-14
Tissue Inhibitor of Metalloproteinsases 3 Assay added to human services. 13-Jan-14
Vitronectin Assay moved to a different multiplex. 13-Jan-14
Angiotensinogen (AGT) Assay discontinued from all human products. 09-Jan-14
Apolipoprotein D (Apo D) Assay redeveloped using new antibody pair. 07-Jan-14

2013

Assay Description of Change Effective Date
Tissue Inhibitor of Metalloproteinases 3 (TIMP-3) This assay did not meet performance specifications in Serum and results should be used for information purposes only. 05-Dec-13
Ezrin Assay discontinued from all human products. 02-Dec-13
Malondialdehyde-Modified Low-Density Lipoprotein (MDA-LDL) This assay did not meet performance specifications and has been discontinued. 19-Nov-13
Pentraxin-3 (PTX3) This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only. 25-Sep-13
Cadherin-1 (E-CAD) This assay did not meet performance specifications in Serum and results should be used for information purposes only. 26-Apr-13
Pancreatic secretory trypsin inhibitor (TATI) This assay did not meet performance specifications in Serum and results should be used for information purposes only. 26-Apr-13
Tyrosine kinase with Ig and EGF homology domains 1 (Tie-1) This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only. 26-Apr-13
Alpha-2-Macroglobulin (A2M) This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only. 26-Apr-13
S100 calcium-binding protein B (S-100B) This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only. 26-Apr-13
E-selectin This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only. 26-Apr-13
EN-RAGE This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only. 26-Apr-13
Prostate Specific Antigen, total (human) Assay adjusted to meet industry standards. 14-Feb-13
MMP-2 (human) Assay discontinued from all human products. 23-Jan-13
Apo-A1 (human) Updated serum and plasma ranges. Assay adjusted to meet industry standards. 15-Jan-13
NGAL (rodent) Redeveloped using new antibody pair. 15-Jan-13
Angiotensinogen (human) Myriad RBM range under evaluation. 15-Jan-13
MMP-1 (human) Myriad RBM range under evaluation. 15-Jan-13
MMP-7 (human) Myriad RBM range under evaluation. 15-Jan-13
MMP-10 (human) Myriad RBM range under evaluation. 15-Jan-13
MMP-9, total (human) Myriad RBM range under evaluation. 15-Jan-13
Peroxiredoxin-4 (human) Assay discontinued from all human products. 8-Jan-13
Protein S100 A6 (human) Assay discontinued from all human products. 8-Jan-13